Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Short Interest Update

Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) was the target of a significant decrease in short interest in February. As of February 28th, there was short interest totalling 9,700 shares, a decrease of 86.7% from the February 13th total of 73,200 shares. Based on an average daily volume of 132,300 shares, the short-interest ratio is currently 0.1 days.

Tevogen Bio Stock Performance

Shares of Tevogen Bio stock traded down $0.00 during midday trading on Wednesday, hitting $0.06. The company had a trading volume of 53,632 shares, compared to its average volume of 159,705. Tevogen Bio has a 12-month low of $0.01 and a 12-month high of $0.15. The company has a fifty day simple moving average of $0.07 and a 200 day simple moving average of $0.05.

About Tevogen Bio

Tevogen Bio Holdings Inc operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients.